The effects of midodrine on patients with liver cirrhosis and refractory ascites: a randomized controlled trial
Background: Splanchnic vasodilation is a significant contributor to the development of ascites in cirrhotic patients. So, midodrine, an alpha-one agonist, may improve circulatory abnormality in cirrhotic patients via its vasoconstrictive action, thus lessening refractory ascites.Aim: To assess the e...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
african journal of gastroenterology and hepatology
2023-11-01
|
| Edice: | African Journal of Gastroenterology and Hepatology |
| Témata: | |
| On-line přístup: | https://ajgh.journals.ekb.eg/article_325751_8bad6c7e00932478283d46e9659448ec.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|